We have previously shown that BCR-ABL-expressing CML cells secreted high levels of osteopontin, a component of the hematopoietic niche capable to induce HSC quiescence [50] (Figure1). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.